ACTUATE THERAPEUTICS, INC. — All Filings
154 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS EX
S-1
S-1/A
S-3
S-8
SC 13D
SCHEDULE 13D/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | FORM 10-K FOR DEC 2025 | 0001683168-26-002257 | Mar 26, 2026 | Dec 31, 2025 |
| 4 | — | 0001683168-26-001039 | Feb 13, 2026 | — |
| 8-K | FORM 8-K | 0001683168-26-000217 | Jan 12, 2026 | — |
| 4 | — | 0001011438-26-000005 | Jan 7, 2026 | Jan 5, 2026 |
| SCHEDULE 13G | — | 0001730145-25-000035 | Dec 17, 2025 | — |
| 144 | — | 0001683168-25-009069 | Dec 11, 2025 | — |
| 8-K | CURRENT REPORT | 0001683168-25-008732 | Nov 28, 2025 | — |
| 424B5 | SUPPLEMENT TO PROSPECTUS DATED 9-8-25 | 0001683168-25-008730 | Nov 28, 2025 | — |
| 8-K | FORM 8-K | 0001683168-25-008618 | Nov 21, 2025 | — |
| 10-Q | FORM 10-Q FOR SEP 2025 | 0001683168-25-008323 | Nov 13, 2025 | Sep 30, 2025 |
| 8-K | CURRENT REPORT | 0001683168-25-006831 | Sep 10, 2025 | — |
| 424B5 | PROSPECTUS | 0001683168-25-006829 | Sep 10, 2025 | — |
| 424B5 | 424B5 | 0001683168-25-006782 | Sep 9, 2025 | — |
| EFFECT | — | 9999999995-25-002878 | Sep 8, 2025 | — |
| CORRESP | — | 0001683168-25-006692 | Sep 4, 2025 | — |
| CORRESP | — | 0001683168-25-006624 | Sep 2, 2025 | — |
| S-3 | REGISTRATION STATEMENT | 0001683168-25-006622 | Sep 2, 2025 | — |
| UPLOAD | — | 0000000000-25-009111 | Aug 26, 2025 | — |
| DRS | — | 0001683168-25-006280 | Aug 18, 2025 | — |
| 10-Q | FORM 10-Q FOR JUN 2025 | 0001683168-25-006159 | Aug 14, 2025 | Jun 30, 2025 |
| EFFECT | — | 9999999995-25-002471 | Aug 4, 2025 | — |
| 424B3 | FORM 424B3 | 0001683168-25-005641 | Aug 4, 2025 | — |
| CORRESP | — | 0001683168-25-005548 | Jul 31, 2025 | — |
| UPLOAD | — | 0000000000-25-008061 | Jul 31, 2025 | — |
| S-1 | REGISTRATION STATEMENT | 0001683168-25-005402 | Jul 25, 2025 | — |
| D | — | 0001683168-25-004957 | Jul 7, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-063993 | Jun 30, 2025 | Jun 27, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-063992 | Jun 30, 2025 | Jun 27, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-063991 | Jun 30, 2025 | Jun 27, 2025 |
| SCHEDULE 13D/A | — | 0001104659-25-063957 | Jun 30, 2025 | — |
| 8-K | CURRENT REPORT | 0001683168-25-004766 | Jun 26, 2025 | Jun 25, 2025 |
| 8-K | CURRENT REPORT | 0001683168-25-004258 | Jun 5, 2025 | May 31, 2025 |
| 8-K | FORM 8-K | 0001683168-25-004117 | Jun 2, 2025 | May 31, 2025 |
| SCHEDULE 13D/A | — | 0001104659-25-052987 | May 27, 2025 | — |
| 4 | — | 0001683168-25-004001 | May 23, 2025 | May 22, 2025 |
| 8-K | FORM 8-K | 0001683168-25-003995 | May 23, 2025 | May 22, 2025 |
| 4 | — | 0001683168-25-003993 | May 23, 2025 | May 22, 2025 |
| 4 | — | 0001683168-25-003990 | May 23, 2025 | May 22, 2025 |
| 4 | — | 0001683168-25-003988 | May 23, 2025 | May 22, 2025 |
| 4 | — | 0001683168-25-003992 | May 23, 2025 | May 22, 2025 |
| 4 | — | 0001683168-25-003991 | May 23, 2025 | May 22, 2025 |
| S-8 | S-8 | 0001683168-25-003707 | May 15, 2025 | — |
| 10-Q | FORM 10-Q FOR MAR 2025 | 0001683168-25-003705 | May 15, 2025 | Mar 31, 2025 |
| 8-K | FORM 8-K | 0001683168-25-003163 | May 6, 2025 | — |
| EFFECT | — | 9999999995-25-001131 | Apr 16, 2025 | — |
| 424B3 | PROSPECTUS | 0001683168-25-002638 | Apr 16, 2025 | — |
| CORRESP | — | 0001683168-25-002547 | Apr 14, 2025 | — |
| D | — | 0001683168-25-002420 | Apr 10, 2025 | — |
| DEFA14A | ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS | 0001683168-25-002345 | Apr 9, 2025 | — |
| DEF 14A | DEFINITIVE PROXY | 0001683168-25-002344 | Apr 8, 2025 | May 22, 2025 |